Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05924477 · ClinicalTrials.gov registry record · NA

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

A NA study of Glaucoma, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
226
Enrollment target
8
Study locations

NCT05924477 is a NA study of Glaucoma that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 226 participants, below the 908-participant average among 92 other Glaucoma trials with a reported enrollment target (75% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05924477, a NA study of Glaucoma, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
226 participants
Enrollment target
8
Study locations

Study Summary

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris and front chamber of the eye) in efforts to minimize cell loss in the eye.

Conditions Studied

Glaucoma

Interventions

  • PROCEDURE Sulcus tube placement
  • PROCEDURE Anterior chamber (AC) tube placement

Study Locations (8)

California

  • University of California San Francisco - San Francisco
  • Diablo Eye Associates - Walnut Creek

Florida

  • Bascom Palmer Eye Institute - Miami

Maryland

  • Wilmer Eye Institute, Johns Hopkins University - Baltimore

Massachusetts

  • Massachusetts Eye and Ear - Boston

New York

  • University of Buffalo/State University of New York - Buffalo

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Other

  • Prism Eye Institute, University of Toronto - Toronto

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2023-07-11
Est. Completion 2027-12
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05924477

The ClinicalTrials.gov registry entry for NCT05924477 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 908-participant average among 92 other Glaucoma trials with a reported enrollment target (75% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Sulcus tube placement is the first listed.

NCT05924477 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Maryland.

Frequently Asked Questions

What is clinical trial NCT05924477 about?

NCT05924477 is a clinical study titled "Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial". Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris ...

What is the current status of trial NCT05924477?

This trial is currently recruiting. It is a NA study. The enrollment target is 226 participants. The study started on 2023-07-11. Estimated completion is 2027-12.

What conditions does trial NCT05924477 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT05924477?

The interventions under investigation include: Sulcus tube placement (PROCEDURE), Anterior chamber (AC) tube placement (PROCEDURE).

Who is sponsoring clinical trial NCT05924477?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05924477 being conducted?

This trial has 8 study locations across California, Florida, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.